Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide.

Mariotti J, Taurino D, Marino F, Bramanti S, Sarina B, Morabito L, De Philippis C, Di Vito C, Mavilio D, Carlo-Stella C, Della Porta M, Santoro A, Castagna L.

Cancer Med. 2020 Jan;9(1):52-61. doi: 10.1002/cam4.2607. Epub 2019 Nov 8.

2.

Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma.

Mariotti J, Devillier R, Bramanti S, Giordano L, Sarina B, Furst S, Granata A, Maisano V, Pagliardini T, De Philippis C, Kogan M, Faucher C, Harbi S, Chabannon C, Carlo-Stella C, Bouabdallah R, Santoro A, Blaise D, Castagna L.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1810-1817. doi: 10.1016/j.bbmt.2019.05.017. Epub 2019 May 22.

PMID:
31128326
3.

Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients.

Granata A, Fürst S, Bramanti S, Legrand F, Sarina B, Harbi S, De Philippis C, Faucher C, Chabannon C, Lemarie C, Calmels B, Mariotti J, Maisano V, Weiller PJ, Mokart D, Vey N, Bouabdallah R, Castagna L, Blaise D, Devillier R.

Bone Marrow Transplant. 2019 Nov;54(11):1730-1737. doi: 10.1038/s41409-019-0500-x. Epub 2019 Mar 19.

PMID:
30890770
4.

Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes.

Bramanti S, Calafiore V, Longhi E, Mariotti J, Crespiatico L, Sarina B, De Philippis C, Nocco A, Santoro A, Castagna L.

Biol Blood Marrow Transplant. 2019 Jul;25(7):1395-1406. doi: 10.1016/j.bbmt.2019.02.020. Epub 2019 Mar 1.

PMID:
30826463
5.

The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide.

Mariotti J, Granata A, Bramanti S, Devillier R, Furst S, Sarina B, Harbi S, Legrand F, Faucher C, Weiller PJ, Chabannon C, Carlo-Stella C, Santoro A, Blaise D, Castagna L.

Bone Marrow Transplant. 2019 Jul;54(7):1164-1167. doi: 10.1038/s41409-019-0453-0. Epub 2019 Jan 24.

PMID:
30679826
6.

Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide.

Mariotti J, De Philippis C, Bramanti S, Sarina B, Tordato F, Pocaterra D, Casari E, Carlo-Stella C, Santoro A, Castagna L.

Eur J Haematol. 2019 Apr;102(4):357-367. doi: 10.1111/ejh.13214. Epub 2019 Feb 13.

PMID:
30672611
7.

The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation.

Roberto A, Di Vito C, Zaghi E, Mazza EMC, Capucetti A, Calvi M, Tentorio P, Zanon V, Sarina B, Mariotti J, Bramanti S, Tenedini E, Tagliafico E, Bicciato S, Santoro A, Roederer M, Marcenaro E, Castagna L, Lugli E, Mavilio D.

Haematologica. 2018 Aug;103(8):1390-1402. doi: 10.3324/haematol.2017.186619. Epub 2018 Apr 26.

8.

A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.

Sarina B, Mariotti J, Bramanti S, Morabito L, Crocchiolo R, Rimondo A, Tordato F, Pocaterra D, Casari E, De Philippis C, Carlo-Stella C, Santoro A, Castagna L.

Transpl Infect Dis. 2018 Aug;20(4):e12906. doi: 10.1111/tid.12906. Epub 2018 May 16.

PMID:
29668124
9.

Genomic Integration of HHV-6 Mimicking Viral Reactivation after Autologous Stem Cell Transplantation.

Mineri R, Mariotti J, Sarina B, Morabito L, Crocchiolo R, Bramanti S, Sarno T, Tordato F, Carlo-Stella C, Santoro A, Castagna L.

Mediterr J Hematol Infect Dis. 2018 Feb 15;10(1):e2018013. doi: 10.4084/MJHID.2018.013. eCollection 2018.

10.

Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma.

Mariotti J, Bramanti S, Devillier R, Furst S, El Cheikh J, Sarina B, Granata A, Faucher C, Harbi S, Morabito L, Weiller PJ, Chabannon C, Mokart J, Mineri R, Carlo-Stella C, Santoro A, Blaise D, Castagna L.

Bone Marrow Transplant. 2018 Mar;53(3):366-370. doi: 10.1038/s41409-017-0032-1. Epub 2017 Dec 21. No abstract available.

PMID:
29269800
11.

T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.

Mariotti J, Devillier R, Bramanti S, Sarina B, Furst S, Granata A, Faucher C, Harbi S, Morabito L, Chabannon C, Carlo-Stella C, Bouabdallah R, Santoro A, Blaise D, Castagna L.

Biol Blood Marrow Transplant. 2018 Mar;24(3):627-632. doi: 10.1016/j.bbmt.2017.11.030. Epub 2017 Nov 29.

12.

New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?

Patriarca F, Giaccone L, Onida F, Castagna L, Sarina B, Montefusco V, Mussetti A, Mordini N, Maino E, Greco R, Peccatori J, Festuccia M, Zaja F, Volpetti S, Risitano A, Bassan R, Corradini P, Ciceri F, Fanin R, Baccarani M, Rambaldi A, Bonifazi F, Bruno B.

Expert Opin Biol Ther. 2017 Jul;17(7):821-836. doi: 10.1080/14712598.2017.1324567. Epub 2017 May 22. Review.

PMID:
28506131
13.

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.

Castagna L, Bramanti S, Devillier R, Sarina B, Crocchiolo R, Furst S, El-Cheikh J, Granata A, Faucher C, Harbi S, Morabito L, Mariotti J, Puvinathan S, Weiller PJ, Chabannon C, Mokart D, Carlo-Stella C, Bouabdallah R, Santoro A, Blaise D.

Bone Marrow Transplant. 2017 May;52(5):797. doi: 10.1038/bmt.2017.26. No abstract available.

PMID:
28465624
14.

Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen.

Dodero A, Patriarca F, Milone G, Sarina B, Miceli R, Iori A, Barretta F, Terruzzi E, Mussetti A, Pini M, Bosi A, Dominietto A, Cascavilla N, Onida F, Narni F, Farina L, Rambaldi A, Corradini P.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1102-1109. doi: 10.1016/j.bbmt.2017.03.031. Epub 2017 Apr 5.

15.

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.

Castagna L, Bramanti S, Devillier R, Sarina B, Crocchiolo R, Furst S, El-Cheikh J, Granata A, Faucher C, Harbi S, Morabito L, Mariotti J, Puvinathan S, Weiller PJ, Chabannon C, Mokart D, Carlo-Stella C, Bouabdallah R, Santoro A, Blaise D.

Bone Marrow Transplant. 2017 May;52(5):683-688. doi: 10.1038/bmt.2016.348. Epub 2017 Jan 16. Erratum in: Bone Marrow Transplant. 2017 May;52(5):797.

PMID:
28092347
16.

Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation.

Castagna L, Sarina B, Crocchiolo R, Bramanti S, Furst S, Devillier R, Coso D, Bouabdallah R, Mokart D, Morabito L, Harbi S, Giordano L, Rimondo A, Jean Weiller P, Carlo-Stella C, Santoro A, Chabannon C, Blaise D.

Bone Marrow Transplant. 2016 Dec;51(12):1644-1646. doi: 10.1038/bmt.2016.257. Epub 2016 Oct 17. No abstract available.

PMID:
27748737
17.

Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor.

Crocchiolo R, Giordano L, Rimondo A, Bologna M, Sarina B, Morabito L, Bramanti S, Castagna L, Mineri R.

J Clin Virol. 2016 Nov;84:24-26. doi: 10.1016/j.jcv.2016.09.008. Epub 2016 Sep 20.

PMID:
27669362
18.

The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.

Rimondo A, Crocchiolo R, El-Cheikh J, Bramanti S, Granata A, Furst S, Sarina B, Morabito L, Devillier R, Harbi S, Mohty B, Mineri R, Faucher C, Chabannon C, Santoro A, Blaise D, Castagna L.

Bone Marrow Transplant. 2017 Jan;52(1):135-137. doi: 10.1038/bmt.2016.193. Epub 2016 Jul 18. No abstract available.

PMID:
27427919
19.

Donor lymphocyte infusion after allogeneic stem cell transplantation.

Castagna L, Sarina B, Bramanti S, Perseghin P, Mariotti J, Morabito L.

Transfus Apher Sci. 2016 Jun;54(3):345-55. doi: 10.1016/j.transci.2016.05.011. Epub 2016 May 13. Review.

PMID:
27216544
20.

Desensitization with plasma exchange in a patient with human leukocyte antigen donor-specific antibodies before T-cell-replete haploidentical transplantation.

Bramanti S, Nocco A, Mauro E, Milone G, Morabito L, Sarina B, Crocchiolo R, Timofeeva I, Capizzuto R, Carlo-Stella C, Santoro A, Castagna L.

Transfusion. 2016 May;56(5):1096-1100. doi: 10.1111/trf.13523. Epub 2016 Mar 28.

PMID:
27021516
21.

The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide.

Crocchiolo R, Castagna L, Furst S, Devillier R, Sarina B, Bramanti S, El-Cheikh J, Granata A, Harbi S, Morabito L, Faucher C, Rimondo A, Girardi D, Mohty B, Calmels B, Carlo-Stella C, Chabannon C, Bouabdallah R, Santoro A, Vey N, Weiller PJ, Blaise D.

Bone Marrow Transplant. 2016 Aug;51(8):1134-6. doi: 10.1038/bmt.2016.69. Epub 2016 Mar 21. No abstract available.

PMID:
26999460
22.

Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide.

Castagna L, Bramanti S, Furst S, Giordano L, Sarina B, Crocchiolo R, El-Cheikh J, Granata A, Morabito L, Mauro E, Faucher C, Mohty B, Harbi S, Devillier R, Chabannon C, Carlo-Stella C, Santoro A, Blaise D.

Bone Marrow Transplant. 2016 Mar;51(3):470. doi: 10.1038/bmt.2015.327. No abstract available.

PMID:
26931485
23.

Bone marrow donor-related variables associated with harvest outcome in HLA-haploidentical transplantation with postinfusion cyclophosphamide.

Rimondo A, Bramanti S, Crocchiolo R, Giordano L, Sarina B, Morabito L, Perotti C, Timofeeva I, Capizzuto R, Santoro A, Castagna L.

Vox Sang. 2016 Jul;111(1):93-100. doi: 10.1111/vox.12385. Epub 2016 Feb 25.

PMID:
26919536
24.

Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide.

Castagna L, Bramanti S, Furst S, Giordano L, Sarina B, Crocchiolo R, El-Cheikh J, Granata A, Morabito L, Mauro E, Faucher C, Mohty B, Harbi S, Devillier R, Chabannon C, Carlo-Stella C, Santoro A, Blaise D.

Bone Marrow Transplant. 2016 Mar;51(3):462-5. doi: 10.1038/bmt.2015.289. Epub 2015 Nov 23. No abstract available. Erratum in: Bone Marrow Transplant. 2016 Mar;51(3):470. Cheikh, J El [corrected to El-Cheikh, J].

PMID:
26595078
25.

T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes.

Devillier R, Bramanti S, Fürst S, Sarina B, El-Cheikh J, Crocchiolo R, Granata A, Chabannon C, Morabito L, Harbi S, Faucher C, Santoro A, Weiller PJ, Vey N, Carlo-Stella C, Castagna L, Blaise D.

Bone Marrow Transplant. 2016 Feb;51(2):194-8. doi: 10.1038/bmt.2015.270. Epub 2015 Nov 9.

PMID:
26551778
26.

Comparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide.

El-Cheikh J, Crocchiolo R, Vai A, Furst S, Bramanti S, Sarina B, Granata A, Faucher C, Mohty B, Harbi S, Bouabdallah R, Vey N, Santoro A, Chabannon C, Castagna L, Blaise D.

Mediterr J Hematol Infect Dis. 2015 Aug 20;7(1):e2015048. doi: 10.4084/MJHID.2015.048. eCollection 2015.

27.

Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients.

Crocchiolo R, Castagna L, Garciaz S, Fürst S, El Cheikh J, Sarina B, Bramanti S, Granata A, Vai A, Harbi S, Morabito L, Mohty B, Giordano L, Devillier R, Coso D, Balzarotti M, Chabannon C, Carlo-Stella C, Santoro A, Bouabdallah R, Blaise D.

Haematologica. 2015 Oct;100(10):e423-7. doi: 10.3324/haematol.2015.129452. Epub 2015 Jul 23. No abstract available.

28.

Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT.

Mancosu P, Navarria P, Castagna L, Reggiori G, Stravato A, Gaudino A, Sarina B, Tomatis S, Scorsetti M.

Phys Med. 2015 Nov;31(7):677-82. doi: 10.1016/j.ejmp.2015.05.012. Epub 2015 Jun 9.

PMID:
26068115
29.

In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study.

Mancosu P, Navarria P, Reggiori G, Cozzi L, Fogliata A, Gaudino A, Lobefalo F, Paganini L, Palumbo V, Sarina B, Stravato A, Castagna L, Tomatis S, Scorsetti M.

Radiat Oncol. 2015 Apr 12;10:86. doi: 10.1186/s13014-015-0391-y.

30.

Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.

Roberto A, Castagna L, Zanon V, Bramanti S, Crocchiolo R, McLaren JE, Gandolfi S, Tentorio P, Sarina B, Timofeeva I, Santoro A, Carlo-Stella C, Bruno B, Carniti C, Corradini P, Gostick E, Ladell K, Price DA, Roederer M, Mavilio D, Lugli E.

Blood. 2015 Apr 30;125(18):2855-64. doi: 10.1182/blood-2014-11-608406. Epub 2015 Mar 5.

31.

Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.

El-Cheikh J, Crocchiolo R, Furst S, Bramanti S, Sarina B, Granata A, Vai A, Lemarie C, Faucher C, Mohty B, Harbi S, Bouabdallah R, Vey N, Santoro A, Chabannon C, Castagna L, Blaise D.

Cancer. 2015 Jun 1;121(11):1809-16. doi: 10.1002/cncr.29271. Epub 2015 Feb 3.

32.

Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis.

Crocchiolo R, Bramanti S, Vai A, Sarina B, Mineri R, Casari E, Tordato F, Mauro E, Timofeeva I, Lugli E, Mavilio D, Carlo-Stella C, Santoro A, Castagna L.

Transpl Infect Dis. 2015 Apr;17(2):242-9. doi: 10.1111/tid.12365.

PMID:
25648539
33.

High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant.

Castagna L, Crocchiolo R, Giordano L, Bramanti S, Carlo-Stella C, Sarina B, Chiti A, Mauro E, Gandolfi S, Todisco E, Balzarotti M, Anastasia A, Magagnoli M, Brusamolino E, Santoro A.

Bone Marrow Transplant. 2015 Apr;50(4):499-504. doi: 10.1038/bmt.2014.304. Epub 2015 Jan 26.

PMID:
25621797
34.

B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY.

Roberto A, Castagna L, Gandolfi S, Zanon V, Bramanti S, Sarina B, Crocchiolo R, Todisco E, Carlo-Stella C, Tentorio P, Timofeeva I, Santoro A, Della Bella S, Roederer M, Mavilio D, Lugli E.

Bone Marrow Transplant. 2015 Feb;50(2):317-9. doi: 10.1038/bmt.2014.266. Epub 2014 Nov 24. No abstract available.

PMID:
25419693
35.

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas.

Castagna L, Bramanti S, Furst S, Giordano L, Crocchiolo R, Sarina B, Mauro E, Morabito L, Bouabdallah R, Coso D, Balzarotti M, Broussais F, El-Cheikh J, Stella CC, Brusamolino E, Blaise D, Santoro A.

Bone Marrow Transplant. 2014 Dec;49(12):1475-80. doi: 10.1038/bmt.2014.197. Epub 2014 Sep 15. Erratum in: Bone Marrow Transplant. 2014 Dec;49(12):1552.

PMID:
25222502
36.

Bendamustine combined with donor lymphocytes infusion in Hodgkin's lymphoma relapsing after allogeneic hematopoietic stem cell transplantation.

Sala E, Crocchiolo R, Gandolfi S, Bruno-Ventre M, Bramanti S, Peccatori J, Sarina B, Corti C, Ciceri F, Santoro A, Marktel S, Castagna L.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1444-7. doi: 10.1016/j.bbmt.2014.05.024. Epub 2014 Jun 4.

37.

Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation.

Mariotti J, Maura F, Spina F, Roncari L, Dodero A, Farina L, Montefusco V, Carniti C, Sarina B, Patriarca F, Rambaldi A, Onida F, Olivieri A, Zallio F, Corradini P.

Biol Blood Marrow Transplant. 2014 Jun;20(6):885-90. doi: 10.1016/j.bbmt.2014.02.015. Epub 2014 Feb 28.

38.

Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.

Castagna L, Crocchiolo R, Furst S, Bramanti S, El Cheikh J, Sarina B, Granata A, Mauro E, Faucher C, Mohty B, Harbi S, Chabannon C, Carlo-Stella C, Santoro A, Blaise D.

Biol Blood Marrow Transplant. 2014 May;20(5):724-9. doi: 10.1016/j.bbmt.2014.02.001. Epub 2014 Feb 13.

39.

Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy.

Mancosu P, Navarria P, Castagna L, Reggiori G, Sarina B, Tomatis S, Alongi F, Nicolini G, Fogliata A, Cozzi L, Scorsetti M.

Med Phys. 2013 Nov;40(11):111713. doi: 10.1118/1.4823767.

PMID:
24320421
40.

First-line extracorporeal photochemotherapy for acute GVHD after unmanipulated haploidentical BMT following nonmyeloablative conditioning and post transplantation CY.

Castagna L, Morabito L, Mauro E, Perotti C, Bramanti S, Sarina B, Giordano L, Crocchiolo R, Santoro A.

Bone Marrow Transplant. 2014 Feb;49(2):317-8. doi: 10.1038/bmt.2013.174. Epub 2013 Nov 11. No abstract available.

PMID:
24212560
41.

Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma.

Raiola A, Dominietto A, Varaldo R, Ghiso A, Galaverna F, Bramanti S, Todisco E, Sarina B, Giordano L, Ibatici A, Santoro A, Clavio M, Bacigalupo A, Castagna L.

Bone Marrow Transplant. 2014 Feb;49(2):190-4. doi: 10.1038/bmt.2013.166. Epub 2013 Nov 4.

PMID:
24185585
42.

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation.

Martínez C, Canals C, Sarina B, Alessandrino EP, Karakasis D, Pulsoni A, Sica S, Trneny M, Snowden JA, Kanfer E, Milpied N, Bosi A, Guidi S, de Souza CA, Willemze R, Arranz R, Jebavy L, Hellmann A, Sibon D, Oneto R, Luan JJ, Dreger P, Castagna L, Sureda A; Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Ann Oncol. 2013 Sep;24(9):2430-4. doi: 10.1093/annonc/mdt206. Epub 2013 May 26.

43.

Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines?

Scarfò L, Zibellini S, Tedeschi A, Maura F, Neri A, Bertazzoni P, Sarina B, Nalli G, Motta M, Rossini F, Cortelezzi A, Montillo M, Orlandi E, Ghia P.

Leukemia. 2012 Jul;26(7):1703-7. doi: 10.1038/leu.2012.20. Epub 2012 Jan 30. No abstract available.

PMID:
22285997
44.

ECIL 3-2009 update guidelines for antifungal management.

Castagna L, Bramanti S, Sarina B, Todisco E, Ibatici A, Santoro A.

Bone Marrow Transplant. 2012 Jun;47(6):866. doi: 10.1038/bmt.2011.154. Epub 2011 Aug 8. No abstract available.

PMID:
21822314
45.

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients.

Visani G, Malerba L, Stefani PM, Capria S, Galieni P, Gaudio F, Specchia G, Meloni G, Gherlinzoni F, Giardini C, Falcioni S, Cuberli F, Gobbi M, Sarina B, Santoro A, Ferrara F, Rocchi M, Ocio EM, Caballero MD, Isidori A.

Blood. 2011 Sep 22;118(12):3419-25. doi: 10.1182/blood-2011-04-351924. Epub 2011 Aug 3.

PMID:
21816830
46.

Allogeneic transplantation for Hodgkin's lymphoma.

Corradini P, Sarina B, Farina L.

Br J Haematol. 2011 Feb;152(3):261-72. doi: 10.1111/j.1365-2141.2010.08492.x. Epub 2010 Dec 13. Review.

PMID:
21155760
47.

Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability.

Sarina B, Castagna L, Farina L, Patriarca F, Benedetti F, Carella AM, Falda M, Guidi S, Ciceri F, Bonini A, Ferrari S, Malagola M, Morello E, Milone G, Bruno B, Mordini N, Viviani S, Levis A, Giordano L, Santoro A, Corradini P; Gruppo Italiano Trapianto di Midollo Osseo.

Blood. 2010 May 6;115(18):3671-7. doi: 10.1182/blood-2009-12-253856. Epub 2010 Mar 10.

48.

Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support.

Castagna L, Bramanti S, Levis A, Michieli MG, Anastasia A, Mazza R, Giordano L, Sarina B, Todisco E, Gregorini AI, Santoro A.

Ann Oncol. 2010 Jul;21(7):1482-5. doi: 10.1093/annonc/mdp576. Epub 2009 Dec 11.

PMID:
20007996
49.

Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre study.

Cortelezzi A, Pasquini MC, Gardellini A, Gianelli U, Bossi A, Reda G, Sarina B, Musto P, Barcellini W, Neri A, Deliliers GL.

Leukemia. 2009 Nov;23(11):2027-33. doi: 10.1038/leu.2009.148. Epub 2009 Jul 30.

50.

Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy.

Castagna L, Bramanti S, Balzarotti M, Sarina B, Todisco E, Anastasia A, Magagnoli M, Mazza R, Nozza A, Giordano L, Rodari M, Rinifilo E, Chiti A, Santoro A.

Br J Haematol. 2009 May;145(3):369-72. doi: 10.1111/j.1365-2141.2009.07645.x. Epub 2009 Mar 5.

PMID:
19344403

Supplemental Content

Loading ...
Support Center